孕期糖尿病管理在初怀孕妇女:一个定性研究
Kalyani Rath1, Moonjelly Vijayan Smitha2
1Obstetrics and Gynaecology, Kalinga Institute of Nursing Sciences, Bhubaneswar, IND.
Cureus
|August 27, 2025
概括
孕期糖尿病 (GDM) 的初生母亲会经历严重的情绪困扰和生活方式变化的挑战. 改善文化敏感的支持和产后护理对于有效管理GDM至关重要.
科学领域:
- 公共卫生
- 内分泌学
- 心理学
背景情况:
- 孕期糖尿病 (GDM) 是一个重大的公共卫生挑战,特别是在印度.
- 关于被诊断患有GDM的初怀孕妇女的经历的研究有限.
研究的目的:
- 探讨被诊断患有GDM的孕期妇女的情绪反应.
- 研究这一群体的自我管理实践,支持系统和医疗互动.
主要方法:
- 这是一项定性现象学研究,涉及18名患有GDM的初怀孕妇女.
- 通过使用NVivo软件进行主题分析.
主要成果:
- 主要主题包括关于GDM诊断的震惊,焦虑,恐惧和自我责怪.
- 改变生活方式 (饮食,血糖监测,体育活动) 的挑战是显著的.
- 社会支持至关重要,但由于社区意识较低,
- 医疗互动有所不同,沟通和同情感影响了信任;未来的糖尿病风险和复发是令人担忧的.
结论:
- 孕期女性面临着多方面的情感,文化和实际挑战.
- 文化适应的指导,同情的照顾,强有力的社会支持和延长产后跟踪是必不可少的.
- 整体护理改善可以提高自我管理,改善结果,减少糖尿病负担.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy
362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
291
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
291
Diabetes: Symptoms, Diagnosis, and Complications
687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687


